Become A Featured Company

Earth Science Tech Brings High Grade CBD To 50 States Via Volume Inventory Model

Ryan Allway

September 23rd, 2014

News, Top Story

By now nearly everyone has heard of the case of Charlotte Figi, a seven-year-old girl with Dravet Syndrome (a form of severe and intractable epilepsy), who was having as many as 50 seizures a day. In desperation, Charlotte’s parents tried everything pharmaceutical science could throw at the problem, even debilitating drugs like barbiturates and benzodiazepines, in an ultimately futile attempt to curb the devastation. The father finally took the leap to try a low-THC (Tetrahydrocannabinol, the psychoactive component), CBD-rich (Cannabidiol) strain of medical marijuana known as Charlotte’s Web and since dosing, his daughter has truly thrived, with only two to three seizures per month and a much-improved overall condition. A groundbreaking clinical trial is coming up to study Charlotte’s Web in Dravet Syndrome at the University of Colorado and this study’s results could provide a real boost to the CBD, as well as broader, medical marijuana markets.

The CBD market in particular has been growing by leaps and bounds in recent years, with heavy-hitters like GW Pharmaceuticals (NASDAQ: GWPH) already seeing good traction on their Multiple Sclerosis treatment, Sativex®, which clearly benefits a great deal from CBD’s increasingly apparent pain-relieving, anti-inflammatory, and immunodulatory effects. Smaller players like CannaVEST Corp. (OTC:CANV) are finding the market wide open too and CannaVEST has managed to establish a considerable CBD supply business, while also working on a range of industrial hemp-derived CBD nutraceuticals. Industrial hemp is widely known for its low THC levels and comparatively higher levels of CBD, making it an ideal source for developing health and wellness products intended to treat a whole host of conditions, from chronic pain and epilepsy, to diabetes. Even various neurological disorders like ADHD and Parkinson’s disease are among the immediate prospects for CBD-rich offerings, according to Project CBD.

CBD has even been shown to promote nutritional health in aging people, acting as an antioxidant and neuroprotectant, superbly suited to age-related inflammatory and autoimmune diseases. Pair the 10,000-plus Baby Boomers retiring per day (Pew Research) and Research and Markets’ latest report on the U.S. nutraceutical market indicating a projected 6% CAGR through 2017, as the space swells to some $75.3B or more, and you get a perfect storm for CBD nutraceuticals.

Ready-Supply Inventory Model, Maximum Distribution Potential

One of the more compelling plays in the space today is Earth Science Tech, Inc. (OTCQB: ETST), which recently received its first two shipments of non-psychoactive, food-grade, CBD-enriched hemp oil, which is completely legal in 50 states and over 40 countries worldwide (as per U.S. Hemp Foods specifications). With over 50 liters from their first two shipments, an initial order already out the door to an outlet in Fort Lauderdale and management working hard to drum up additional supply lines, Earth Science Tech is rapidly moving towards widespread commercialization while setting themselves up to be a high-volume throughput channel for high-grade CBD. Perhaps more importantly, management is steadfastly committed to genuinely helping consumers get the best nutrition and dosing information possible, as well as creating shareholder upside. This was clearly demonstrated by the CEO in a recent video interview with leading cannabis investment news source, CannabisFN, when he said a salary won’t be pursued until he knows the company is doing well.

Earth Science Tech has already begun making their CBD product available online in half-ounce, ounce and two ounce bottles, and has made sizeable investments into their high-volume inventory model, with hundreds of thousands of dollars already outlaid and ambitions to fill persistent supply constraints in the CBD market via a steady stream of readily available product. Earth Science Tech has even funded assistant dean of the University of Central Oklahoma’s College of Mathematics and Science, Wei R. Chen, Ph.D., with a $10k grant to study the anti-tumor effects of the such hemp oil enriched with CBD on cancer cells, pushing the boundaries of the established anti-tumor properties of CBD. Dr. Chen brings an impressive track record of over two decades in cancer research to the project as its lead and has noted that the project may result in a new understanding of the potential applications of this non-toxic and largely beneficial natural product.

Developing Nutraceutical Portfolio, Retail Footprint

Beyond raw CBD enriched hemp oil, Earth Science Tech is seeking to develop a variety of nutraceuticals, bioceuticals and dietary supplements for health, wellness, sports and alternative medicine, as well as natural alternatives to prescription medications, both CBD and non-CBD based. This is the same model employed to great success by companies like LifeVantage Corp. (NASDAQ: LFVN), which notably cropped out into sports nutrition recently, extending their reach from a strong base in nutraceutical dietary supplements.

Earth Science Tech has developed a unique menopause and perimenopause formula for aging women known as ProgesteBeauty™, and the company is currently in the process of opening the first retail location for their wholly-owned Nutrition Empire, Inc. subsidiary in an upscale area of Coral Gables, Florida. The retail footprint will help support product roll outs and the company will also be working to dovetail their overall commercial presence with key strategic partners and third party resellers who already control chunks of the nutritional and supplement markets.

Earth Science Tech has secured a lease for their initial retail location, which is situated right on the edge of the University of Miami campus, on the first floor of a luxury apartment complex, that stipulates no other nutrition or supplement store will be located within a three-mile radius. The location is right by a 24k square foot gourmet grocery store as well, in a premier shopping district with loads of foot traffic. This will also be the first retail store in all of Dade County where consumers can walk right in and buy CBD oil over the counter, as well as get their hands on ProgesteBeauty, or the company’s soon-to-be-released, oxygen-based colon cleanser with probiotics (L. rhamnosus and L. acidophilus), OxyBiotic™. The goal is to have around 600 best-in-class health and wellness products in-store, as well as a terminal for customers to order products for next-day delivery, again emphasizing ready supply as a key brand hallmark.

Spartan Management Leveraging Top Consultants

Unlike many other companies in a similar position, which might tend to bloat the management team with a lot of extraneous personnel in order to try and cover all their bases, ETST has opted to create a lean and mean management team, tapping the best of the best in requisite fields to act as consultants. By maintaining a network of top-quality consultants, the kind of expert formulators responsible for the company’s ProgesteBeauty and OxyBiotic formulas, ETST aims to keep management expenses down and yet remain highly competitive in the space.

For More Information Visit Earth Science Tech’s Company Website

Sign Up For Future Email Updates On Earth Science Tech:

http://www.tdmfinancial.com/emailassets/etst/etst_landing.php

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

Disclaimer: Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Network Partners

Follow Us on Social Media

LinkedIn

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading